Literature DB >> 12778475

CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.

Florian Gantner1, Patrice Hermann, Kosuke Nakashima, Satoko Matsukawa, Katsuya Sakai, Kevin B Bacon.   

Abstract

Immunostimulatory CpG oligodeoxynucleotide (CpG-ODN) sequences are known to directly activate B cells. We investigated the expression of the CpG receptor, Toll-like receptor 9 (TLR9), in human tonsil B cells, and determined functional responses following stimulation by a well-characterized stimulatory CpG-containing ODN sequence in the human immune system, ODN 2006. Tonsil B cells were found to express high amounts of TLR9 mRNA and protein, and exposure of B cells to CpG-ODN but not to an inactive control ODN induced a concentration- and time-dependent up-regulation of the activation markers CD23, CD25, CD40, CD54, CD80, CD86 and HLA-DR. However, significant induction of proliferation and the release of IL-6, IL-10, IgG and IgM were only noted when B cells were co-incubated with irradiated CD40L-expressing CHO cells. Endogenous IL-10 was identified as a critical mediator of Ig production, whereas all activating effects were independent of IL-6. Further, CpG-ODN counteracted IgE production induced by IL-4. Collectively, these findings suggest a synergistic role of the TLR9/CD40 system and a critical role for the immunomodulatory cytokine IL-10 in the orchestration of CpG-ODN-induced responses in B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12778475     DOI: 10.1002/eji.200323444

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

Review 1.  Regulatory B cells in autoimmunity: developments and controversies.

Authors:  Claudia Mauri; Paul A Blair
Journal:  Nat Rev Rheumatol       Date:  2010-09-21       Impact factor: 20.543

2.  Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production.

Authors:  Nina Kim; Sesquile Ramon; Thomas H Thatcher; Collynn F Woeller; Patricia J Sime; Richard P Phipps
Journal:  Eur J Immunol       Date:  2015-11-02       Impact factor: 5.532

3.  CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

Authors:  Jennifer Huggins; Tina Pellegrin; Raymond E Felgar; Chungwen Wei; Miguel Brown; Bo Zheng; Eric C B Milner; Steven H Bernstein; Ignacio Sanz; Martin S Zand
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

4.  Role of B cells in common variable immune deficiency.

Authors:  Sam Ahn; Charlotte Cunningham-Rundles
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

Review 5.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

6.  Syk is indispensable for CpG-induced activation and differentiation of human B cells.

Authors:  Mariann Kremlitzka; Bernadett Mácsik-Valent; Anna Erdei
Journal:  Cell Mol Life Sci       Date:  2014-12-28       Impact factor: 9.261

Review 7.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

8.  Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.

Authors:  Esra Ozcan; Ingrid Rauter; Lilit Garibyan; Stacey R Dillon; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2011-07-07       Impact factor: 10.793

Review 9.  Male infertility: a public health issue caused by sexually transmitted pathogens.

Authors:  Fabrícia Gimenes; Raquel P Souza; Jaqueline C Bento; Jorge J V Teixeira; Silvya S Maria-Engler; Marcelo G Bonini; Marcia E L Consolaro
Journal:  Nat Rev Urol       Date:  2014-10-21       Impact factor: 14.432

Review 10.  Matchmaking the B-cell signature of tolerance to regulatory B cells.

Authors:  A S Chong; R Sciammas
Journal:  Am J Transplant       Date:  2011-10-03       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.